Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. Co.'s product candidate, GB-102, is an intravitreal injection of a microparticle depot formulation of sunitinib, a potent inhibitor of neovascular growth and permeability, which are causes of retinal disease. Co.'s second product candidate, GB-401, is an intravitreally administered, proprietary implant formulation containing a prodrug of a beta-adrenergic receptor inhibitor developed to provide a controlled release of the active drug to maintain reduced intraocular pressure, for six months or longer after a single injection. We show 10 historical shares outstanding datapoints in our GRAY shares outstanding history coverage, used to compute GRAY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GRAY market cap history over the course of time is important for investors
interested in comparing GRAY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GRAY versus a peer is one thing; comparing
GRAY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GRAY can fluctuate over the course of history.
With this page we aim to empower investors researching GRAY by allowing them to research the GRAY market cap history. |
Free GRAY Email Alerts:
Video: The Importance of Market Cap
